Chuck Royce's HRMY Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 356,671 shares of Harmony Biosciences Holdings, Inc. (HRMY) worth $9.99 M, representing 0.10% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in HRMY, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 196,430 shares. Largest reduction occurred in Q4 2023, reducing 170,746 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Harmony Biosciences Holdings (HRMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Harmony Biosciences Holdings (HRMY) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +78,483 | Add 28.21% | 356,671 | $28.01 |
| Q4 2025 | +196,430 | Add 240.26% | 278,188 | $37.42 |
| Q3 2025 | +259 | Add 0.32% | 81,758 | $27.56 |
| Q2 2025 | -260 | Reduce 0.32% | 81,499 | $31.60 |
| Q4 2024 | +3,056 | Add 3.88% | 81,759 | $34.41 |
| Q3 2024 | -11,413 | Reduce 12.66% | 78,703 | $40.00 |
| Q2 2024 | -8,122 | Reduce 8.27% | 90,116 | $30.17 |
| Q1 2024 | -11,365 | Reduce 10.37% | 98,238 | $33.58 |
| Q4 2023 | -170,746 | Reduce 60.90% | 109,603 | $32.30 |
| Q3 2023 | +60,770 | Add 27.68% | 280,349 | $32.77 |
| Q2 2023 | -112,750 | Reduce 33.93% | 219,579 | $35.19 |
| Q1 2023 | +102,059 | Add 44.32% | 332,329 | $32.65 |
| Q4 2022 | -65,740 | Reduce 22.21% | 230,270 | $55.10 |
| Q3 2022 | +27,813 | Add 10.37% | 296,010 | $44.29 |
| Q2 2022 | +12,390 | Add 4.84% | 268,197 | $48.77 |
| Q1 2022 | +36,723 | Add 16.76% | 255,807 | $48.65 |
| Q4 2021 | -10,306 | Reduce 4.49% | 219,084 | $42.64 |
| Q3 2021 | +101,340 | Add 79.14% | 229,390 | $38.33 |
| Q2 2021 | +128,050 | New Buy | 128,050 | $28.23 |
Chuck Royce's Harmony Biosciences Holdings Investment FAQs
Chuck Royce first purchased Harmony Biosciences Holdings, Inc. (HRMY) in Q2 2021, acquiring 128,050 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Harmony Biosciences Holdings, Inc. (HRMY) for 20 quarters since Q2 2021.
Chuck Royce's largest addition to Harmony Biosciences Holdings, Inc. (HRMY) was in Q4 2025, adding 278,188 shares worth $10.41 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 356,671 shares of Harmony Biosciences Holdings, Inc. (HRMY), valued at approximately $9.99 M.
As of the Q1 2026 filing, Harmony Biosciences Holdings, Inc. (HRMY) represents approximately 0.10% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Harmony Biosciences Holdings, Inc. (HRMY) was 356,671 shares, as reported at the end of Q1 2026.